XML 82 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies (Comparison of Financial Statements as Previously Filed - Statement of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended 12 Months Ended
Jun. 29, 2014
Jun. 30, 2013
Dec. 29, 2013
Net earnings (loss) $ 9,725 $ (20,913) $ (18,927)
Depreciation and amortization 12,490 13,666  
Amortization of debt issuance costs 217 821  
Interest on financing liability 1,127 1,013  
Deferred taxes   (768)  
Stock-based compensation 2,898 3,859  
Provision for losses on accounts receivable 473 (522)  
Excess tax benefit on stock compensation (79) (122)  
Loss on disposal of fixed assets 81 375  
Litigation settlement 0 (6,584)  
Gain on sale of subsidiary 0 (248)  
Loss on sale of discontinued operations 0 13,024  
Restructuring-related asset impairment   731  
Accounts receivable 26,398 37,308  
Inventories (16,527) (2,529)  
Other current assets 3,357 148  
Accounts payable (7,625) 8,267  
Income taxes (2,341) (2,329)  
Unearned revenues - current 985 (3,840)  
Restructuring reserve   (5,059)  
Other liabilities (7,421) (19,339)  
Net cash provided by operating activities 21,299 16,959  
Acquisition of property, plant, and equipment and intangibles (6,774) (3,310)  
Cash proceeds from the sale of discontinued operations 142 1,290  
Cash proceeds from the sale of subsidiary 0 227  
Other investing activities 44 921  
Net cash used in investing activities (6,588) (872)  
Proceeds from stock issuances 951 1,545  
Excess tax benefit on stock compensation 79 122  
Proceeds from short-term debt 0 2,759  
Payment of short-term debt 0 (2,561)  
Net change in factoring and bank overdrafts (107) (339)  
Payment of long-term debt (7,198) (10,113)  
Net cash used in financing activities (5,232) (8,587)  
Effect of foreign currency rate fluctuations on cash and cash equivalents 374 (3,204)  
Net increase in cash and cash equivalents 9,853 4,296  
Beginning of period 121,573 118,829 118,829
End of period 131,426 123,125 121,573
As Previously Reported
     
Net earnings (loss)   (19,357)  
Depreciation and amortization   14,487  
Amortization of debt issuance costs   0  
Interest on financing liability   0  
Deferred taxes   (305)  
Stock-based compensation   3,859  
Provision for losses on accounts receivable   (522)  
Excess tax benefit on stock compensation   (122)  
Loss on disposal of fixed assets   375  
Litigation settlement   (6,584)  
Gain on sale of subsidiary   (248)  
Loss on sale of discontinued operations   13,024  
Restructuring-related asset impairment   731  
Accounts receivable   41,613  
Inventories   (2,456)  
Other current assets   2,690  
Accounts payable   3,351  
Income taxes   (2,329)  
Unearned revenues - current   (7,007)  
Restructuring reserve   (5,059)  
Other liabilities   (19,182)  
Net cash provided by operating activities   16,959  
Acquisition of property, plant, and equipment and intangibles   (3,310)  
Cash proceeds from the sale of discontinued operations   1,290  
Cash proceeds from the sale of subsidiary   227  
Other investing activities   921  
Net cash used in investing activities   (872)  
Proceeds from stock issuances   1,545  
Excess tax benefit on stock compensation   122  
Proceeds from short-term debt   2,759  
Payment of short-term debt   (2,561)  
Net change in factoring and bank overdrafts   (339)  
Payment of long-term debt   (10,113)  
Net cash used in financing activities   (8,587)  
Effect of foreign currency rate fluctuations on cash and cash equivalents   (3,204)  
Net increase in cash and cash equivalents   4,296  
Beginning of period   118,829 118,829
End of period   123,125  
Restatement Adjustments
     
Net earnings (loss)   (1,556)  
Depreciation and amortization   0  
Amortization of debt issuance costs   0  
Interest on financing liability   1,013  
Deferred taxes   (463)  
Stock-based compensation   0  
Provision for losses on accounts receivable   0  
Excess tax benefit on stock compensation   0  
Loss on disposal of fixed assets   0  
Litigation settlement   0  
Gain on sale of subsidiary   0  
Loss on sale of discontinued operations   0  
Restructuring-related asset impairment   0  
Accounts receivable   (4,305)  
Inventories   (73)  
Other current assets   (2,542)  
Accounts payable   4,916  
Income taxes   0  
Unearned revenues - current   3,167  
Restructuring reserve   0  
Other liabilities   (157)  
Net cash provided by operating activities   0  
Acquisition of property, plant, and equipment and intangibles   0  
Cash proceeds from the sale of discontinued operations   0  
Cash proceeds from the sale of subsidiary   0  
Other investing activities   0  
Net cash used in investing activities   0  
Proceeds from stock issuances   0  
Excess tax benefit on stock compensation   0  
Proceeds from short-term debt   0  
Payment of short-term debt   0  
Net change in factoring and bank overdrafts   0  
Payment of long-term debt   0  
Net cash used in financing activities   0  
Effect of foreign currency rate fluctuations on cash and cash equivalents   0  
Net increase in cash and cash equivalents   0  
Beginning of period   0 0
End of period   $ 0